🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.45
-1.05 (-6.36%)
Nov 20, 2026, 1:30 PM CST

TPE:3164 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
92.7103.73110.5155.6133.69169.95
Short-Term Investments
279.1261.62248.13272.71267.26251.78
Cash & Short-Term Investments
371.8365.36358.64328.3400.94421.73
Cash Growth
16.77%1.87%9.24%-18.12%-4.93%-9.33%
Accounts Receivable
49.5146.1631.638.2350.3654.01
Other Receivables
1.790.741.731.791.41.05
Receivables
51.346.8933.3340.0251.7655.06
Inventory
71.3770.3977.6788.1255.337.06
Prepaid Expenses
4.985.234.929.0713.4966.94
Other Current Assets
71.2267.4467.17---
Total Current Assets
570.66555.31541.73465.51521.5580.79
Property, Plant & Equipment
979.46976.291,0371,0601,1131,045
Long-Term Investments
--6.097.3226.5234.68
Other Intangible Assets
1.932.012.162.260.240.33
Long-Term Deferred Tax Assets
51.8451.8442.0439.722.7312.31
Other Long-Term Assets
83.3479.6479.8978.2911.5924.8
Total Assets
1,6871,6651,7091,6531,6961,698

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
13.298.146.37.8514.3711.39
Short-Term Debt
45.2723.520.48---
Current Portion of Long-Term Debt
7.117.3112.242.24--
Current Portion of Leases
2.361.762.42.361.062.11
Current Income Taxes Payable
16.4822.7412.1918.9528.4433.82
Current Unearned Revenue
22.8722.0440.0533.9825.7625.33
Other Current Liabilities
40.6944.2946.4881.0191.1666.51
Total Current Liabilities
148.07129.78140.15146.39160.78139.17
Long-Term Debt
40.3144.949.2320.11--
Long-Term Leases
37.2732.8434.2633.633.4930.62
Long-Term Deferred Tax Liabilities
5.525.523.111.591.961.54
Other Long-Term Liabilities
2.322.322.322.372.372.32
Total Liabilities
233.48215.35229.07204.06198.59173.65

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
860.1860.1865.11865.11863.71863.71
Additional Paid-In Capital
334.57351.77353.74377.1375.69375.69
Retained Earnings
98.95113.34128.0289.97117.5154.87
Comprehensive Income & Other
42.515.664.9-15.88-5.58-17.83
Total Common Equity
1,3361,3311,3521,3161,3511,376
Minority Interest
117.61118.85127.9132.82145.89147.95
Shareholders' Equity
1,4541,4501,4801,4491,4971,524
Total Liabilities & Equity
1,6871,6651,7091,6531,6961,698

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
132.32110.31118.6158.3134.5532.73
Net Cash (Debt)
239.48255.05240.03270366.4389
Net Cash Growth
12.75%6.26%-11.10%-26.31%-5.81%-9.70%
Net Cash Per Share
2.752.952.773.124.234.48
Filing Date Shares Outstanding
87.6386.0186.5186.5186.3786.37
Total Common Shares Outstanding
87.6386.0186.5186.5186.3786.37
Working Capital
422.6425.53401.59319.12360.73441.62
Book Value Per Share
15.2515.4715.6315.2215.6515.94
Tangible Book Value
1,3341,3291,3501,3141,3511,376
Tangible Book Value Per Share
15.2315.4515.6015.1915.6415.93
Buildings
-926.21923.19886.14877.91168.74
Machinery
-492.34489.48481.71419.15234.11
Construction In Progress
--0.020.0375.24858.62